Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2770077 | Revista de la Sociedad Española del Dolor | 2009 | 8 Pages |
Abstract
Irrespective of the policy of generic drug use and given the potency of fentanyl and the possible changes in plasma concentration when one brand is changed to another, we believe that, to maintain analgesic effect and avoid the development of adverse effects, any change should be authorized by the physician originally prescribing the drug or by the physician responsible for the patient's care.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
L.M. Torres, F. Collado, J. MartÃnez-Vázquez de Castro, E. Calderón, J. Sánchez-Pardo, J.L. Molano, C. del Álamo,